Consensus ESG Ratings
Member Sign In
ESG News For Alexion Pharmaceuticals, Inc.
These sites contributed news to this page:
-
Global Genes Launches RARE Patient Identification and Inclusion Initiative to Address Critical Gaps in Diagnosis, Research and Trials for Rare Neurological Conditions
Partners Include Child Neurology Foundation, Passage Bio, Alexion, SIO Gene Therapies and Taysha Gene Therapies -
Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees
- Ahead of Rare Disease Day, new support becomes available to the rare community - -
Alexion Employees Volunteer Together to Enhance Their Local Communities during Second Annual Global Day of Service
Alexion announced more than 1,300 employees are supporting service initiatives as part of the Company’s second annual Global Day of Service.